OSI is an ISO 13485:2003 registered company.
Ocular Systems, Inc. featured in Winston-Salem JournalPosted March 12, 2012 WINSTON-SALEM, March 12, 2012 – Ocular Systems, Inc (OSI) is pleased to announce that it has been featured in the Business section of the March 11th edition of the Winston-Salem Journal. Click here to read the full article. Jerry Barker Wins Piedmont Triad Biotechnology Excellence AwardPosted March 9, 2012 WINSTON-SALEM, March 9, 2012 – Ocular Systems, Inc (OSI) is pleased to announce that Jerry Barker, President of OSI, is the recipient of the 2012 Piedmont Triad Biotechnology Excellence Award for Entrepreneurial Excellence. The Entrepreneurial Excellence Award recognizes Barkers’ successful endeavors in commercial enterprise development in the biotech industry. Barker was presented the award during the 2012 Triad BioNight event held at the Sheraton Greensboro at Four Seasons on March 8th. Ocular Systems Receives FDA 510(k) Clearance for EndoSerter®Posted February 21, 2011 Ocular Systems, Inc. (OSI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the company’s human corneal endothelium delivery instrument, the EndoSerter®. The device delivers a corneal endothelial allograft measuring ≤ 8.5mm in diameter and ≤ 175µm in central thickness through a single 4 mm incision during endothelial keratoplasty procedures. Endothelial keratoplasty, a type of corneal transplantation that does not require a full-thickness graft, has become the treatment of choice for restoring corneal clarity to patients with failed endothelium function. Click here to read the full release Jamie Swaim Receives CEBT CertificationPosted May 10, 2010 Ocular Systems Inc is pleased to announce that Jamie Swaim has passed the Eye Bank Association of America Certified Eye Bank Technician examination (CEBT). Mr. Swaim becomes the sixth member of the OSI team to achieve CEBT status. This certification evaluates an individual’s knowledge of donor screening, testing, evaluation, processing, distribution and regulatory compliance for eye tissue intended for transplantation. Maintenance of this certification requires a program of continuing education through association activities, and we congratulate him on his achievement. Ocular Systems Appoints Kilmora Consulting as Endosaver® Distribution ManagerPosted April 23, 2010 Ocular Systems has contracted John McMaster of Kilmorna Consulting to identify and establish European Union distributor relationships for its corneal endothelium delivery instrument, EndoSaver®. McMaster is an experienced, high-performing ophthalmic device sales consultant who will formulate market strategy and guide OSI’s international business. Before he established Kilmorna Consulting, John McMaster managed the non-US business for CooperVision Surgical. Ocular Systems’ Endosaver® Honored With European Union’s CE MarkPosted April 22, 2010 Ocular Systems, Inc. today announced that its corneal endothelium delivery instrument, EndoSaver® has received the European Union’s CE Mark. The CE Mark certifies that EndoSaver® has met the EU’s health and safety standards, and permits the company to begin marketing and sales across the European Economic Community and in other countries recognizing the CE Mark. EndoSaver® is a sterile, single-use, disposable corneal endothelium delivery instrument. Its use preserves donor endothelium during implantation of allograft tissue in patients undergoing endothelial keratoplasty procedures, a type of corneal transplantation. EndoSaver® is used to insert corneal endothelial allograft tissue measuring less than or equal to 8.5mm in diameter and up to 175 microns in central thickness into the eye’s anterior chamber through a 4.0mm incision. Ocular Systems Receives ISO CertificationPosted March 24, 2010 Ocular Systems, Inc. has received ISO 13485: 2003 Certification for manufacture and distribution of ophthalmic surgical instruments. Ocular Systems, based in the Piedmont Triad Research Park, Winston-Salem, North Carolina, manufactures EndoSaver®, a human corneal endothelium delivery instrument. Ocular Systems, Inc. President Jerry Barker Named Ernst & Young Entrepreneur Of The Year® 2009 Award Finalist in the CarolinasPosted May 15, 2009 Ocular Systems, Inc. (OSI) today announced that its president, Jerry Barker, is a finalist for the Ernst & Young Entrepreneur Of The Year® 2009 Award in the Carolinas. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Barker was selected as a finalist from nearly 75 nominations by a panel of independent judges. Award winners will be announced at a special gala event on June 18, 2009 at the Westin Charlotte. Click here to read the full article. Ocular Systems Profiled in Business Journal of the Greater TriadPosted February 27, 2009 It looks a bit like a plain electric toothbrush, but a new medical device jointly developed by Ocular Systems Inc. and Wake Forest University promises to make a cutting-edge eye surgery less painstaking for doctors while giving a boost to the young company’s bottom line. Click here to read the full article. Corneal Tissue Reimbursement Consulting Now AvailablePosted April 4, 2008 Ocular Systems is pleased to provide its customers with reimbursement consulting to help guide you in billing corneal tissue to your local Medicare carrier and other commercial insurance carriers. Reimbursement for the acquisition of tissue used during keratoplasty procedures is a major concern for providers, patients, the physician community and medical technology innovators.
NMD is fully prepared to receive and respond to all of OSI customer’s coding, coverage and reimbursement inquiries. OSI customers may access reimbursement information by contacting NMD Healthcare directly by phone at: NMD offices (609) 584-8470. You may also contact NMD by email at: support@nmdhealthcare.com. |
